Suppression of early atherosclerosis in LDL-receptor deficient mice by oral tolerance with beta 2-glycoprotein I.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Cardiovascular Research

• Publication date

  2004-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.CARDIORES.2004.01.028PMID 15158153
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Circulating autoantibodies to oxidized cardiolipin correlate with isoprostane F(2alpha)-VI levels and the extent of atherosclerosis in ApoE-deficient mice: modulation by vitamin E.

  2001cited by this paper
• Adoptive transfer of beta(2)-glycoprotein I-reactive lymphocytes enhances early atherosclerosis in LDL receptor-deficient mice.

  2000cited by this paper
• Monocyte Tissue Factor Induction by Activation of β2-Glycoprotein-I-Specific T Lymphocytes Is Associated with Thrombosis and Fetal Loss in Patients with Antiphospholipid Antibodies1

  2000cited by this paper
• Adoptive Transfer of β2-Glycoprotein I–Reactive Lymphocytes Enhances Early Atherosclerosis in LDL Receptor–Deficient Mice

  2000cited by this paper
• Requisite role for interleukin-4 in the acceleration of fatty streaks induced by heat shock protein 65 or Mycobacterium tuberculosis.

  2000cited by this paper
• Induction of Neonatal Tolerance to Oxidized Lipoprotein Reduces Atherosclerosis In ApoE Knockout Mice

  2000cited by this paper
• Protective role of interleukin-10 in atherosclerosis.

  1999cited by this paper
• IL-4 and IL-10 are both required for the induction of oral tolerance.

  1999cited by this paper
• Oral tolerance: mechanisms and therapeutic applications.

  1999cited by this paper
• Immunolocalization of (cid:98) 2 -Glycoprotein I (Apolipoprotein H) to Human Atherosclerotic Plaques Potential Implications for Lesion Progression Brief Rapid Communication

  1999cited by this paper
• Atherosclerosis is an Inflammatory Disease

  1998cited by this paper
• Induction of early atherosclerosis in LDL-receptor-deficient mice immunized with beta2-glycoprotein I.

  1998cited by this paper
• Oral tolerance to low dose beta 2-glycoprotein I: immunomodulation of experimental antiphospholipid syndrome.

  1998cited by this paper
• Immunologic tolerance to myelin basic protein decreases stroke size after transient focal cerebral ischemia.

  1997cited by this paper
• Immune Clearance of Phosphatidylserine-expressing Cells by Phagocytes

  1997cited by this paper
• Immunology of the antiphospholipid antibody syndrome.

  1996cited by this paper
• Oral Tolerance in Experimental Autoimmune Encephalomyelitis

  1996cited by this paper
• The serum concentration of active transforming growth factor-β is severely depressed in advanced atherosclerosis

  1995cited by this paper
• Peripheral deletion of antigen-reactive T cells in oral tolerance

  1995cited by this paper
• Is atherosclerosis an immunologically mediated disease?

  1995cited by this paper
• Beta2-Glycoprotein I

  1994cited by this paper
• The oxidation hypothesis of atherosclerosis.

  1994cited by this paper
• Oral tolerance: immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens.

  1994cited by this paper
• Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis.

  1994cited by this paper
• Induction of anergy or active suppression following oral tolerance is determined by antigen dosage.

  1994cited by this paper
• The antiphospholipid syndrome: ten years on.

  1993cited by this paper
• Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery.

  1993cited by this paper
• Oral tolerance in experimental autoimmune encephalomyelitis. III. Evidence for clonal anergy.

  1991cited by this paper
• Involvement of the immune system in human atherogenesis: current knowledge and unanswered questions.

  1991cited by this paper
• Antigen-driven bystander suppression after oral administration of antigens

  1991cited by this paper
• Quantitative assessment of atherosclerotic lesions in mice.

  1987cited by this paper
• Proteins as molecular chaperones

  1987cited by this paper

• Peptidic vaccines: The new cure for heart diseases?

  2020cites this paper
• Mucosal Administration of E-selectin Limits Disability in Models of Multiple Sclerosis

  2019cites this paper
• Readapting the adaptive immune response – therapeutic strategies for atherosclerosis

  2017cites this paper
• Readapting the adaptive immune response – therapeutic strategies for atherosclerosis

  2017cites this paper
• Immune regulation by oral tolerance induces alternate activation of macrophages and reduces markers of plaque destabilization in Apobtm2Sgy/Ldlrtm1Her/J mice

  2017cites this paper
• Regulating Inflammatory Immune Response to Atherogenic Antigens Prevents Development and Progression of Atherosclerosis in New Zealand White Rabbits.

  2016cites this paper
• Chlamydomonas reinhardtii chloroplasts express an orally immunogenic protein targeting the p210 epitope implicated in atherosclerosis immunotherapies

  2016cites this paper
• Adaptive Response of T and B Cells in Atherosclerosis.

  2016cites this paper
• Intranasal immunization with heat shock protein 60 induces CD4+CD25+GARP+ and type 1 regulatory T cells and inhibits early atherosclerosis

  2016cites this paper
• Oral administration of recombinant Mycobacterium smegmatis expressing a tripeptide construct derived from endogenous and microbial antigens prevents atherosclerosis in ApoE(-/-) mice.

  2016cites this paper
• Treating atherosclerosis with regulatory T cells.

  2015cites this paper
• Attenuation of early atherosclerotic lesions by immunotolerance with β2 glycoprotein I and the immunomodulatory effectors interleukin 2 and 10 in a murine model.

  2015cites this paper
• TYPE-II COLLAGEN DERIVED FROM MARINE ENVIRONS: AN EXTENDED REVIEW FOR ITS MECHANISM OF ACTION IN ORAL TOLERANCE AND ITS BIOMARKERS FOR THE DETECTION OF ARTHRITIS DISEASE IN EARLIER STAGE

  2015cites this paper
• Modulation of autoimmunity and atherosclerosis - common targets and promising translational approaches against disease.

  2015cites this paper
• Mucosal Administration of Collagen V Ameliorates the Atherosclerotic Plaque Burden by Inducing Interleukin 35-dependent Tolerance*

  2015cites this paper
• Oral dosing with multi-antigenic construct induces atheroprotective immune tolerance to individual peptides in mice.

  2014cites this paper
• Modulation of Atherosclerotic Lesions by Circulating Cells : The Translational Spectrum Series

  2014cites this paper
• Pathogenesis and treatment of atherosclerosis in lupus.

  2014cites this paper
• Chapter 71 – Atherosclerosis

  2014cites this paper
• [Effector and regulatory blood lymphocyte subpopulations in stable coronary artery disease].

  2014cites this paper
• Regulating atherosclerosis via costimulatory and coinhibitory pathways

  2013cites this paper
• Adaptive immunity in atherogenesis: new insights and therapeutic approaches.

  2013cites this paper
• Regulatory T cells in atherosclerosis and strategies to induce the endogenous atheroprotective immune response.

  2013cites this paper
• Mucosal Tolerance to a Combination of ApoB and HSP60 Peptides Controls Plaque Progression and Stabilizes Vulnerable Plaque in Apobtm2SgyLdlrtm1Her/J Mice

  2013cites this paper
• Chapter 26 – Pathogenesis and Treatment of Atherosclerosis in Lupus

  2013cites this paper
• Molecular biology of atherosclerosis.

  2013cites this paper
• Regulation of immune responses in atherosclerosis

  2013cites this paper
• Comparison of Oral Tolerance to ApoB and HSP60 Peptides in Preventing Atherosclerosis Lesion Formation in Apob48−/Ldlr− Mice

  2013cites this paper
• Adoptive transfer of ApoB100 specific T cells in atherosclerosis

  2013cites this paper
• CD4+LAP+ and CD4+CD25+Foxp3+ Regulatory T Cells Induced by Nasal Oxidized Low-Density Lipoprotein Suppress Effector T Cells Response and Attenuate Atherosclerosis in ApoE−/− Mice

  2012cites this paper
• Regulatory T-Cell Response to Apolipoprotein B100–Derived Peptides Reduces the Development and Progression of Atherosclerosis in Mice

  2012cites this paper
• CD4⁺Foxp3⁺ Treg and its ICOS⁺ subsets in patients with myocardial infarction.

  2012cites this paper
• T Lymphocyte Autoreactivity in Inflammatory Mechanisms Regulating Atherosclerosis

  2012cites this paper
• Vascular disease in patients with antiphospholipid syndrome : what do the cardiologists need to know ?

  2012cites this paper
• Vaccination Against Atherosclerosis

  2012cites this paper
• The role of T and B cells in atherosclerosis: potential clinical implications.

  2011cites this paper
• Dynamic Changes in Regulatory T Cells Are Linked to Levels of Diet-Induced Hypercholesterolemia

  2011cites this paper
• The Immune System in Acute Coronary Syndrome

  2011cites this paper
• Vaccine for Atherosclerosis: An Emerging New Paradigm

  2011cites this paper
• Systemic lupus erythematosus and cardiovascular disease: prediction and potential for therapeutic intervention

  2011cites this paper
• Differential effects of regulatory T cells on the initiation and regression of atherosclerosis.

  2011cites this paper
• Intranasal Delivery of E-Selectin Reduces Atherosclerosis in ApoE−/− Mice

  2011cites this paper
• Vaccination against Foxp3(+) regulatory T cells aggravates atherosclerosis.

  2010cites this paper
• Experimental immunotherapeutic approaches for atherosclerosis.

  2010cites this paper
• Safety and efficacy trial of adipose-tissue derived oral preparation V-6 Immunitor (V-6): results of open-label, two-month, follow-up study

  2010cites this paper
• Intranasal Immunization With an Apolipoprotein B-100 Fusion Protein Induces Antigen-Specific Regulatory T Cells and Reduces Atherosclerosis

  2010cites this paper
• Effect of oral immunization with pooled antigens derived from adipose tissue on atherosclerosis and obesity indices.

  2010cites this paper
• Immunomodulation of vascular diseases: atherosclerosis and autoimmunity.

  2010cites this paper
• Vaccination, atherosclerosis and systemic lupus erythematosus

  2009cites this paper
• Downregulation of T helper cell type 3 in patients with acute coronary syndrome.

  2009cites this paper
• Vaccination against atherosclerosis? Induction of atheroprotective immunity

  2009cites this paper
• Innate and adaptive immunity in atherosclerosis

  2009cites this paper
• The potential role of heat shock proteins in cardiovascular disease: evidence from in vitro and in vivo studies.

  2009cites this paper
• A vaccine against atherosclerosis: myth or reality?

  2008cites this paper
• Antiphospholipid Syndrome: Mechanisms Revealed in Erythrocyte and Liposome Studies

  2008cites this paper
• Early atheroma in primary and secondary antiphospholipid syndrome: an intrinsic finding.

  2008cites this paper
• The role of inflammation, humoral and cell mediated autoimmunity in the pathogenesis of atherosclerosis.

  2008cites this paper
• Autoimmunity in atherosclerosis: a protective response losing control?

  2008cites this paper
• Mechanisms of Disease: the evolving role of regulatory T cells in atherosclerosis

  2008cites this paper
• Progression of atherosclerosis in ApoE‐deficient mice that express distinct molecular forms of TNF‐alpha

  2008cites this paper
• Influence of CD4+/CD25+ regulatory T cells on atherogenesis in patients with end-stage kidney disease

  2008cites this paper
• Immunomodulation of the inflammatory response in atherosclerosis

  2007cites this paper
• An insight into the pathophysiology of thrombosis in antiphospholipid syndrome.

  2007cites this paper
• Insights into atherosclerosis therapy in antiphospholipid syndrome.

  2007cites this paper
• Active and passive immunization for atherosclerosis.

  2007cites this paper
• The fine-tuning of anti-oxidized low-density lipoprotein antibodies in cardiovascular disease and thrombosis

  2007cites this paper
• Immunomodulation and its effector mechanisms in atherosclerosis

  2007cites this paper
• OxLDL/beta2GPI-anti-oxLDL/beta2GPI complex and atherosclerosis in SLE patients.

  2007cites this paper
• Systemic Antiphospholipid Syndrome and Atherosclerosis

  2007cites this paper
• Role of Naturally Occurring CD4+CD25+ Regulatory T Cells in Experimental Atherosclerosis

  2007cites this paper
• Induction of oral tolerance to oxidized LDL ameliorates atherosclerosis

  2007cites this paper
• Induction of Oral Tolerance to HSP60 or an HSP60-Peptide Activates T Cell Regulation and Reduces Atherosclerosis

  2007cites this paper
• Antiphospholipid Syndrome — Experimental Models: Insight into Etiology, Pathogenesis, and Treatments

  2006cites this paper
• Heart involvement in systemic lupus erythematosus, anti-phospholipid syndrome and neonatal lupus.

  2006cites this paper
• Altered status of CD4(+)CD25(+) regulatory T cells in patients with acute coronary syndromes.

  2006cites this paper
• Inflammation and atherosclerosis.

  2006cites this paper
• Mechanisms of Disease: atherosclerosis in autoimmune diseases

  2006cites this paper
• IMMUNE MECHANISMS IN ATHEROSCLEROSIS Focus on the Role of the Complement System

  2006cites this paper
• Altered status of CD 4 1 CD 25 1 regulatory T cells in patients with acute coronary syndromes

  2006cites this paper
• Aterosclerose na artrite reumatóide e sua associação com auto-imunidade humoral

  2006cites this paper
• Induction of Oral Tolerance to Oxidized Low-Density Lipoprotein Ameliorates Atherosclerosis

  2006cites this paper
• The antiphospholipid syndrome: clinical characteristics, laboratory features and pathogenesis

  2005cites this paper
• Immune tolerance as a strategy for treatment of atherosclerosis

  2005cites this paper
• Predictive and protective autoimmunity in cardiovascular diseases: is vaccination therapy a reality?

  2005cites this paper
• Nonorgan specific autoantibodies and heart damage

  2005cites this paper
• Inflammation and Type 2 Diabetes: Results from KORA Augsburg

  2005cites this paper
• An immune origin of type 2 diabetes?

  2005cites this paper
• Immunomodulation of atherosclerosis with a vaccine

  2005cites this paper
• Antigen-tailored therapy based on the inflammatory theory of atherosclerosis

  2004cites this paper
• Vaccination for atherosclerosis: a novel therapeutic paradigm

  2004cites this paper